0.8 ML risperidone 150 MG/ML Prefilled Syringe [Perseris]

RxCUI
2055672
RxNorm name
0.8 ML risperidone 150 MG/ML Prefilled Syringe [Perseris]
Display name
0.8 ML risperidone 150 MG/ML Prefilled Syringe [Perseris]
Full name
0.8 ML risperidone 150 MG/ML Prefilled Syringe [Perseris]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:12

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
a4f21b1a-5691-4b14-a56d-651962d06f390.8 ML risperidone 150 MG/ML Prefilled Syringe [Perseris]SBD18These highlights do not include all the information needed to use PERSERIS ® safely and effectively. See full prescribing information for PERSERIS. PERSERIS (risperidone) for extended-release injectable suspension, for subcutaneous use. Initial U.S. Approval: 199320250128
a4f21b1a-5691-4b14-a56d-651962d06f39Perseris 120 MG per 0.8 ML Prefilled SyringeSY18These highlights do not include all the information needed to use PERSERIS ® safely and effectively. See full prescribing information for PERSERIS. PERSERIS (risperidone) for extended-release injectable suspension, for subcutaneous use. Initial U.S. Approval: 199320250128
a4f21b1a-5691-4b14-a56d-651962d06f39PERSERIS 120 MG in 0.8 mL Prefilled SyringePSN18These highlights do not include all the information needed to use PERSERIS ® safely and effectively. See full prescribing information for PERSERIS. PERSERIS (risperidone) for extended-release injectable suspension, for subcutaneous use. Initial U.S. Approval: 199320250128
a4f21b1a-5691-4b14-a56d-651962d06f390.8 ML Perseris 150 MG/ML Prefilled SyringeSY18These highlights do not include all the information needed to use PERSERIS ® safely and effectively. See full prescribing information for PERSERIS. PERSERIS (risperidone) for extended-release injectable suspension, for subcutaneous use. Initial U.S. Approval: 199320250128